Skip to content

A multi-center real-world study for the application of Motherwort injection in the field of family planning after market

A multi-center real-world clinical research program for the application of Motherwort injection in the field of family planning after the market

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000004159
Enrollment
Unknown
Registered
2020-09-28
Start date
2020-10-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, placement or removal of an IUD

Interventions

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. After induced abortion Women of childbearing age who were diagnosed with pregnancy and required abortion were selected as the subjects of the study. And meet the following criteria: 1) Women eligible for induced abortion; 2) Aged18-40 years old, in good health in the past; 3) Can fill in the bleeding card; 4) Volunteer for the study. (2) After placing the IUD Women of childbearing age who were selected for IUD placement were studied. And meet the following criteria: 1) If the IUD is selected and placed as a long-term contraceptive method, or vaginal bleeding >=8 days after the PLACEMENT of the IUD; 2) Can fill in the bleeding card; 3) Volunteer to participate in the study and sign the informed consent. (3) After the IUD is removed Healthy women who had their IUDs removed were selected and studied for reasons such as pregnancy or menopause. And meet the following criteria: 1) Patients aged between 20 and 65 who voluntarily take the ring without surgical contraindications; 2) Can fill in the bleeding card; 3) Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Allergy to this product or excipients listed in motherwort preparation and ingredients or history of serious adverse reactions; 2) Patients with allergic constitution (allergic to motherwort or to motherwort preparation) + pregnant women; 3) Patients whom the researcher considers inappropriate.

Design outcomes

Primary

MeasureTime frame
menstruation recovery time;vagina bleeding time;

Countries

China

Contacts

Public Contactwu haiying
whysunnyzg@163.com+86 13503713179

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026